Spire Healthcare Group PLC Director/PDMR Shareholding (5732I)

TIDMSPI

RNS Number : 5732I

Spire Healthcare Group PLC

31 August 2016

31 August 2016

Spire Healthcare Group plc (the "Company")

On 30 August 2016, the following Directors exercised the second tranche of their vested Directors' Share Bonus Plan awards (the "Awards") over ordinary shares in the Company. The Awards were granted in the form of nil-cost options to Simon Gordon and Garry Watts on 4 July 2014, prior to the Company's Admission to the London Stock Exchange.

Based on the average share price on the second anniversary of Admission, the Awards partially vested and became exercisable on 23 July 2016.

 
 Director        Type of award    Shares vested    Shares    Shareholding 
                                   and exercised    sold*      following 
                                                              transaction 
--------------  ---------------  ---------------  --------  ------------- 
                 Conditional 
                  Share Award 
                  (in the form 
                  of nil-cost 
 Simon Gordon     options)           195,427       92,174      471,758 
--------------  ---------------  ---------------  --------  ------------- 
 Garry Watts                         227,991       107,533     503,577 
-------------------------------  ---------------  --------  ------------- 
 

*All shares sold were at an average share price of 350.4 pence.

Both Directors sold sufficient shares to cover their Income Tax and NIC liabilities and then retained the balance of their Awards.

Further details regarding the Awards are provided within the Company's 2015 Directors' Remuneration Report.

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
----  ---------------------------------------------------------------------- 
 a)    Name                        Simon Gordon 
----  --------------------------  ------------------------------------------ 
 2     Reason for the notification 
----  ---------------------------------------------------------------------- 
 a)    Position/status             Executive Director and Chief Financial 
                                    Officer 
----  --------------------------  ------------------------------------------ 
 b)    Initial notification        Initial notification 
        /Amendment 
----  --------------------------  ------------------------------------------ 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------------------- 
 a)    Name                        Spire Healthcare Group plc 
----  --------------------------  ------------------------------------------ 
 b)    LEI                         n/a 
----  --------------------------  ------------------------------------------ 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ---------------------------------------------------------------------- 
 a)    Description                 Ordinary shares of 1 pence each 
        of the financial 
        instrument, 
        type of instrument 
        Identification 
        code 
----  --------------------------  ------------------------------------------ 
 b)    Nature of                   Exercise of a nil-cost share option 
        the transaction             over 195,427 shares granted under 
                                    the Company's Deferred Bonus Plan 
                                    and subsequent sale of 92,174 
                                    shares stemming from such exercise. 
----  --------------------------  ------------------------------------------ 
 c)    Price(s) and                       Price(s)             Volume(s) 
        volume(s) 
----  --------------------------  -----------------------  ----------------- 
                        350.4 pence                              92,174 
  -------------------------------------------------------  ----------------- 
 
 d)    Aggregated                  As above 
        information 
        - Aggregated 
        volume 
        - Price 
----  --------------------------  ------------------------------------------ 
 e)    Date of the                 2016-08-30 
        transaction 
----  --------------------------  ------------------------------------------ 
 f)    Place of the                XLON 
        transaction 
----  --------------------------  ------------------------------------------ 
 
 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
----  -------------------------------------------------------------------- 
 a)    Name                        Garry Watts 
----  --------------------------  ---------------------------------------- 
 2     Reason for the notification 
----  -------------------------------------------------------------------- 
 a)    Position/status             Executive Chairman 
----  --------------------------  ---------------------------------------- 
 b)    Initial notification        Initial notification 
        /Amendment 
----  --------------------------  ---------------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------------------- 
 a)    Name                        Spire Healthcare Group plc 
----  --------------------------  ---------------------------------------- 
 b)    LEI                         n/a 
----  --------------------------  ---------------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------------------- 
 a)    Description                 Ordinary shares of 1 pence each 
        of the financial 
        instrument, 
        type of instrument 
        Identification 
        code 
----  --------------------------  ---------------------------------------- 
 b)    Nature of                   Exercise of a share option over 
        the transaction             227,991 shares granted under the 
                                    Company's Deferred Bonus Plan 
                                    and subsequent sale of 107,533 
                                    shares stemming from such exercise. 
----  --------------------------  ---------------------------------------- 
 c)    Price(s) and                      Price(s)             Volume(s) 
        volume(s) 
----  --------------------------  ----------------------  ---------------- 
                        350.4 pence                            107,533 
  ------------------------------------------------------  ---------------- 
 
 d)    Aggregated                  As above 
        information 
        - Aggregated 
        volume 
        - Price 
----  --------------------------  ---------------------------------------- 
 e)    Date of the                 2016-08-30 
        transaction 
----  --------------------------  ---------------------------------------- 
 f)    Place of the                XLON 
        transaction 
----  --------------------------  ---------------------------------------- 
 

Enquiries:

Philip Davies

Deputy Company Secretary

020 7427 9092

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBBGDILSXBGLB

(END) Dow Jones Newswires

August 31, 2016 07:48 ET (11:48 GMT)